U.S. regulators have given the green light to updated COVID-19 vaccines designed to more effectively combat recent virus strains and potential variants that may emerge in the upcoming winter months. With the Food and Drug Administration's approval, Pfizer and Moderna are gearing up to distribute millions of doses, while Novavax is expected to follow suit shortly.
The FDA's decision to clear the updated vaccines comes amidst a persistent summer wave of the virus across most of the country. The Centers for Disease Control and Prevention has already recommended the fall shot for individuals aged 6 months and older, emphasizing the importance of staying protected against evolving virus strains.
